Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Virginia Rossetti
Observed name:
V Rossetti
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Istituto Oncologico Romagnolo,
University of Bologna
ORCID:
0000-0001-6052-8729
Observed ORCID:
0000-0001-6052-8729
OpenAlex ID:
A5032842913
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
2023
·
Laura Evangelista
, Andrea Bianchi
, et al.
·
Cancers
·
17
PDF
Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
2020
·
M Celli
, U De Giorgi
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
17
[18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review
2021
·
Federica Matteucci
, Priscilla Guglielmo
, et al.
·
Current Medical Imaging Formerly Current Medical Imaging Reviews
·
10
Performance of FDG PET/ceCT in the evaluation of patients with lung cancer
2014
·
Cristina Nanni
, Virginia Rossetti
, et al.
·
Biomedicine & Pharmacotherapy
·
8
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
2024
·
Emilio Francesco Giunta
, Paola Caroli
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
4
Can Baseline [ 18 F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study
2023
·
Andrea Bianchi
, Maria Luisa De Rimini
, et al.
·
Cancer Biotherapy and Radiopharmaceuticals
·
4
Impact of 68Ga-PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.
2023
·
Amelia Altavilla
, Paola Caroli
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas
2026
·
Ilaria Grassi
, Maddalena Sansovini
, et al.
·
Frontiers in Medicine
·
1
PDF
PSMA for HCC: a new frontier in precision medicine for liver cancer?
2026
·
Paola Caroli
, Virginia Rossetti
, et al.
·
Cancer Treatment and Research Communications
·
1
Choline PET/CT in the PSMA Era: Clinical Repositioning, Biological Perspectives, and Emerging Applications
2026
·
Virginia Rossetti
, Lorenzo Fantini
, et al.
·
Diagnostics
PDF
The Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of the End of Treatment 18-FDG-PET in Diffuse Large B Cell Lymphoma (DLBCL) Patients
2016
·
Raffaella Marcheselli
, Antonella Franceschetto
, et al.
·
Blood
Show more works
View as search
Works count:
11
Citation count:
64
H-index:
4
I10-index:
3
Year
Topic
Type